Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F19%3A73595068" target="_blank" >RIV/61989592:15110/19:73595068 - isvavai.cz</a>

Result on the web

<a href="https://www.termedia.pl/Arthropathic-psoriasis-complicated-by-a-paradoxical-reaction-in-the-form-of-erythrodermic-psoriasis-following-adalimumab-and-by-an-allergic-reaction-following-infliximab-which-was-successfully-managed,7,37483,1,1.html" target="_blank" >https://www.termedia.pl/Arthropathic-psoriasis-complicated-by-a-paradoxical-reaction-in-the-form-of-erythrodermic-psoriasis-following-adalimumab-and-by-an-allergic-reaction-following-infliximab-which-was-successfully-managed,7,37483,1,1.html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/ada.2019.87454" target="_blank" >10.5114/ada.2019.87454</a>

Result language

angličtina

Original language name

Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab

Original language description

Secukinumab, an IL 17R inhibitor, belongs to the new generation of biological agents used for therapy of severe forms of psoriasis. It was approved by the European Medicines Agency for the treatment of psoriasis on January 15th 2015. We describe the case of a young patient with a severe course of arthropathic psoriasis, in whom therapy was associated with a number of complications and whose condition was successfully managed only after several years once secukinumab had been started.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30216 - Dermatology and venereal diseases

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Postepy Dermatologii I Alergologii

ISSN

1642-395X

e-ISSN

—

Volume of the periodical

36

Issue of the periodical within the volume

4

Country of publishing house

PL - POLAND

Number of pages

3

Pages from-to

495-497

UT code for WoS article

000485142200020

EID of the result in the Scopus database

2-s2.0-85072193540